Skip to main content
TipRanks
Go Ultimate75% OFF

Pharmosa Biopharm Inc. (6875) Cash flow

Pharmosa Biopharm Inc. Cash Flow

TW:6875's free cash flow for Q2 2026 was NT$-79.74M. For the 2026 fiscal year, TW:6875's free cash flow was decreased by NT$-22.29M and operating cash flow was NT$-57.45M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Mar 23Dec 21
NT$ -357.48MNT$ -127.16MNT$ 42.42MNT$ -258.31MNT$ -237.51M
NT$ 256.17MNT$ -1.04BNT$ -93.84MNT$ -10.17MNT$ 4.75M
NT$ -16.89MNT$ 942.11MNT$ 352.97MNT$ 479.52MNT$ 279.68M
NT$ 631.23MNT$ 749.44MNT$ 974.06MNT$ 672.51MNT$ 461.46M
NT$ -476.83MNT$ -293.13MNT$ -39.05MNT$ -268.50MNT$ -240.75M

Currency in TWD

Pharmosa Biopharm Inc. Cash Flow

-1.5B-1B-500M0500M1B1.5B2019202020212022202320242025OperatingInvestingFinancing